Reproductive history and risk of three breast cancer subtypes defined by three biomarkers

Cancer Causes and Control

Volumn 22, Issue 3, 2011, Pages 399-405

  Phipps, Amanda I ^a,b   Buist, Diana S M ^b,c   Malone, Kathleen E ^a,b   Barlow, William E ^b,c,d   Porter, Peggy L ^e   Kerlikowske, Karla ^f   Li, Christopher I ^b  

^a Fred Hutchison Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c GROUP HEALTH RESEARCH INSTITUTE   (United States)

^d USA   (United States)

^e UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Age at first birth; Breast cancer; Parity; Triple negative

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER CLASSIFICATION; CANCER RISK; CHILDBIRTH; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MATERNAL AGE; NULLIPARA; PARITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPRODUCTIVE HISTORY; RISK ASSESSMENT;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BREAST NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM STAGING; PARITY; PREGNANCY; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; REPRODUCTIVE HISTORY; RISK FACTORS;

EID: 79955771921     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-010-9709-0     Document Type: Article

References (28)

1. Perou CM, Sorlie T, Eisen MB et al (2000) Molecular portraits of human breast tumours. Nature 406:747-752
2. Sorlie T, Tibshirani R, Parker J et al (2003) Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci USA 100:8418-8423 (Pubitemid 36842560)
3. Sorlie T (2004) Molecular portraits of breast cancer: Tumour subtypes as distinct disease entities. Eur J Cancer 40:2667-2675 (Pubitemid 39574720)
4. Nielsen TO, Hsu FD, Jensen K et al (2004) Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma. Clin Cancer Res 10:5367-5374 (Pubitemid 39100473)
5. Carey LA, Perou CM, Livasy CA et al (2006) Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA 295:2492-2502 (Pubitemid 43854964)
6. Kim MJ, Ro JY, Ahn SH, Kim HH, Kim SB, Gong G (2006) Clinicopathologic significance of the basal-like subtype of breast cancer: A comparison with hormone receptor and Her2/ neu-overexpressing phenotypes. Hum Pathol 37:1217-1226 (Pubitemid 44286991)
7. Lund MJ, Trivers KF, Porter PL et al (2009) Race and triple negative threats to breast cancer survival: A population-based study in Atlanta, GA. Breast Cancer Res Treat 113:357-370
8. Onitilo AA, Engel JM, Greenlee RT, Mukesh BN (2009) Breast cancer subtypes based on ER/PR and Her2 expression: Comparison of clinicopathologic features and survival. Clin Med Res 7:4-13
9. Rakha EA, El-Rehim DA, Paish C et al (2006) Basal phenotype identifies a poor prognostic subgroup of breast cancer of clinical importance. Eur J Cancer 42:3149-3156 (Pubitemid 44854512)
10. Potter JD, Cerhan JR, Sellers TA et al (1995) Progesterone and estrogen receptors and mammary neoplasia in the Iowa Women's Health Study: How many kinds of breast cancer are there? Cancer Epidemiol Biomarkers Prev 4:319-326
11. Althuis MD, Fergenbaum JH, Garcia-Closas M, Brinton LA, Madigan MP, Sherman ME (2004) Etiology of hormone receptordefined breast cancer: A systematic review of the literature. Cancer Epidemiol Biomarkers Prev 13:1558-1568 (Pubitemid 39331875)
12. Rosenberg LU, Einarsdottir K, Friman EI et al (2006) Risk factors for hormone receptor-defined breast cancer in postmenopausal women. Cancer Epidemiol Biomarkers Prev 15:2482-2488 (Pubitemid 46048309)
13. Ma H, Bernstein L, Pike MC, Ursin G (2006) Reproductive factors and breast cancer risk according to joint estrogen and progesterone receptor status: A meta-analysis of epidemiological studies. Breast Cancer Res 8:R43
14. Yang XR, Sherman ME, Rimm DL et al (2007) Differences in risk factors for breast cancer molecular subtypes in a populationbased study. Cancer Epidemiol Biomarkers Prev 16:439-443 (Pubitemid 46548646)
15. Millikan RC, Newman B, Tse CK et al (2008) Epidemiology of basal-like breast cancer. Breast Cancer Res Treat 109:123-139 (Pubitemid 351538762)
16. Ma H, Wang Y, Sullivan-Halley J et al (2010) Use of four biomarkers to evaluate the risk of breast cancer subtypes in the women's contraceptive and reproductive experiences study. Cancer Res 70:575-587
17. Phipps AI, Malone KE, Porter PL, Daling JR, Li CI (2008) Reproductive and hormonal risk factors for postmenopausal luminal, HER-2-overexpressing, and triple-negative breast cancer. Cancer 113:1521-1526
18. Dolle JM, Daling JR, White E et al (2009) Risk factors for triplenegative breast cancer in women under the age of 45 years. Cancer Epidemiol Biomarkers Prev 18:1157-1166
19. Trivers KF, Lund MJ, Porter PL et al (2009) The epidemiology of triple-negative breast cancer, including race. Cancer Causes Control 20:1071-1082
20. Xing P, Li J, Jin F (2010) A case-control study of reproductive factors associated with subtypes of breast cancer in Northeast China. Med Oncol 27(3):926-931
21. Ballard-Barbash R, Taplin SH, Yankaskas BC et al (1997) Breast cancer surveillance consortium: A national mammography screening and outcomes database. AJR Am J Roentgenol 169:1001-1008 (Pubitemid 27406892)
22. http://breastscreening.cancer.gov/data/elements.html
23. http://breastscreening.cancer.gov/data/bcsc-data-definitions.pdf
24. Kalbfleisch JD, Prentice RL (2002) The statistical analysis of failure time data, 2nd edition edn. Wiley, New York
25. Raghunathan TE, Lepkowski JM, Van Hoewyk J, Solenberger P (2001) A multivariate technique for multiply imputing missing values using a sequence of regression models. Surv Method 27:85-95
26. Kelsey JL, Gammon MD, John EM (1993) Reproductive factors and breast cancer. Epidemiol Rev 15:36-47 (Pubitemid 23269069)
27. Clavel-Chapelon F, E3 N-EPIC Group (2002) Differential effects of reproductive factors on the risk of pre- and postmenopausal breast cancer: Results from a large cohort of French women. Br J Cancer 86:723-727 (Pubitemid 34250813)
28. Russo J, Russo IH (1997) Differentiation and breast cancer. Medicina (B Aires) 57(2):81-91 (Pubitemid 127510501)